Appointed
Yi Yang
Director
IPW ·
iPower Inc.
appointed a new director, Yi Yang, to the Board, effective June 5, 2025.
Executive movement radar
Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 3851–3900 of 75328
Appointed
Michael W. Sumruld
Senior Vice President of Finance
OII ·
OCEANEERING INTERNATIONAL INC
Mr. Michael W. Sumruld will join the Company as Senior Vice President of Finance on September 1, 2025, and is expected to succeed Mr. Curtis as Chief Financial Officer upon Mr. Curtis’s retirement from such position.
Departed
Thomas J. Snyder
President of Silgan Containers
SLGN ·
SILGAN HOLDINGS INC
On June 3, 2025, Thomas J. Snyder, President of Silgan Containers, the U.S. metal container operations of Silgan Holdings Inc., or the Company, notified the Company that he was resigning from his position with Silgan Containers to pursue another opportunity.
Appointed
Steven F. Mayer
Director
ARAY ·
ACCURAY INC
On June 3, 2025, the Board appointed Steven F. Mayer to the Board as a Class III director, with a term expiring at the Company’s 2027 annual meeting of stockholders, effective immediately prior to, and contingent upon, the effectiveness of the Financing Agreement.
Departed
Carl L. Gordon
Director
MBX ·
MBX Biosciences, Inc.
Also effective as of June 5, 2025 was the departure of Carl L. Gordon, Ph.D., CFA from the Company's board of directors.
Appointed
Maha Radhakrishnan, M.D.
Director
CADL ·
Candel Therapeutics, Inc.
On June 4, 2025, the Board of Directors (the “Board”) of Candel Therapeutics, Inc. (the “Company”) increased the size of the Board from nine (9) to ten (10) directors and unanimously appointed Maha Radhakrishnan, M.D., to fill the newly created vacancy on the Board, effective June 4, 2025.
Departed
David Shook
Chief Medical Officer and Head of Research & Development
NKTX ·
Nkarta, Inc.
David Shook, M.D. notified Nkarta, Inc. (the “Company”) of his decision to resign as Chief Medical Officer and Head of Research & Development of the Company to pursue other opportunities in the oncology space.
Appointed
Shawn Rose
Chief Medical Officer and Head of Research and Development
NKTX ·
Nkarta, Inc.
Shawn Rose, M.D. Ph.D. has been appointed by the Company to succeed Dr. Shook as Chief Medical Officer and Head of Research and Development starting on June 23, 2025.
Departed
Shahram Ghasemian
Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary
LEU ·
CENTRUS ENERGY CORP
On June 5, 2025, Mr. Shahram Ghasemian, Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Centrus Energy Corp. (the “Company”) provided notice that he will resign from his positions at the Company, effective June 29, 2025, in order to pursue another opportunity.
Appointed
(interim)
Richard Emery
Acting General Counsel, Chief Compliance Officer & Corporate Secretary
LEU ·
CENTRUS ENERGY CORP
Effective upon Mr. Ghasemian's departure, Mr. Richard Emery will be appointed as Acting General Counsel, Chief Compliance Officer & Corporate Secretary of the Company.
Departed
Kurt Darrow
Director
CMS-PB ·
CONSUMERS ENERGY CO
On June 5, 2025, Kurt Darrow, who has served as a member of the CMS Energy Corporation (“CMS Energy”) and Consumers Energy Company (“Consumers”) Boards of Directors (“Boards”) since 2013, informed CMS Energy and Consumers that he has decided to retire from the Boards, effective July 1, 2025.
Appointed
Chen Yi (Jean) Hsu
trustee
Antares Strategic Credit Fund
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Strategic Credit Fund (the “ Company ”) as a trustee.
Appointed
Chen Yi (Jean) Hsu
trustee
Antares Private Credit Fund
Effective as of June 2, 2025, Chen Yi (Jean) Hsu was appointed by the Board of Trustees (the “ Board ”) of Antares Private Credit Fund (the “ Company ”) as a trustee.
Departed
Brent Rhodes
Chief Accounting Officer
HUBG ·
Hub Group, Inc.
On June 2, 2025, Brent Rhodes notified Hub Group, Inc. (the "Company") of his decision to resign from the position of Chief Accounting Officer effective June 27, 2025 ("Effective Date").
Appointed
Dennis Mathews
Chief Accounting Officer
HUBG ·
Hub Group, Inc.
On June 6, 2025, Dennis Mathews was appointed as the Company's Chief Accounting Officer effective June 30, 2025.
Appointed
Conor Hanley
Director
KMTS ·
KESTRA MEDICAL TECHNOLOGIES, LTD.
On June 4, 2025, the Board of Directors (the “Board”) of Kestra Medical Technologies, Ltd. (the “Company”) elected Mr. Conor Hanley as a new member of the Board.
Departed
Tralisa Maraj
Chief Financial Officer
LVWR ·
LiveWire Group, Inc.
On June 6, 2025, Tralisa Maraj, the Chief Financial Officer of LiveWire Group, Inc. (the “Company”), announced her resignation effective July 11, 2025 allowing sufficient time for a transition of her responsibilities before pursuing another opportunity outside the Company.
Departed
Courtney Conigliaro
Chief Financial Officer
OACC ·
Oaktree Acquisition Corp. III Life Sciences
On June 3, 2025, Courtney Conigliaro notified the board of directors (the "Board") of Oaktree Acquisition Corp. III Life Sciences (the "Company") of her resignation as Chief Financial Officer of the Company.
Appointed
Thomas Sweeney
Chief Financial Officer
OACC ·
Oaktree Acquisition Corp. III Life Sciences
On June 3, 2025, the Board appointed Thomas Sweeney as new Chief Financial Officer (principal accounting and principal financial officer) of the Company, effective immediately.
Role change
Jay C. Horgen
Chief Executive Officer
AMG ·
AFFILIATED MANAGERS GROUP, INC.
Jay C. Horgen, previously President and Chief Executive Officer, will continue as Chief Executive Officer of the Company.
Role change
Thomas M. Wojcik
President and Chief Operating Officer
AMG ·
AFFILIATED MANAGERS GROUP, INC.
On June 3, 2025, Thomas M. Wojcik was appointed President of Affiliated Managers Group, Inc. (the “Company”).
Departed
Dr. Marvin S. Hausman
Director
LUDG ·
LUDWIG ENTERPRISES, INC.
On June 5, 2025, the Board of Directors (the “Board”) of Ludwig Enterprises, Inc. (the “Company”) received a letter of resignation from Dr. Marvin S. Hausman from his position on the Board, Dr. Hausman will remain in his position as Chief Scientific Officer of the Company.
Appointed
Samir Elias Hachem Kerbage
Director of the Sponsor
NCIQ ·
Hashdex Nasdaq CME Crypto Index ETF
Effective June 2, 2025, Samir Elias Hachem Kerbage was appointed to the Board of Directors of the Sponsor.
Departed
Bruno Leonardo Kmita de Oliveira Passos
Director of the Sponsor
NCIQ ·
Hashdex Nasdaq CME Crypto Index ETF
On June 2, 2025, Bruno Leonardo Kmita de Oliveira Passos resigned from his role as a member of the Board of Directors of Hashdex Asset Management Ltd. (the “Sponsor”), the sponsor of the Hashdex Nasdaq Crypto Index US ETF (the “Trust”).
Appointed
(interim)
Natalie Russell
Interim Chief Financial Officer
CYN ·
Cyngn Inc.
As previously disclosed, effective June 6, 2025, Natalie Russell, the Company’s Director of Accounting, will serve as the Company’s Interim Chief Financial Officer.
Departed
Donald Alvarez
Chief Financial Officer
CYN ·
Cyngn Inc.
Effective June 6, 2025, Donald Alvarez stepped down as a member of the board of directors (the “Board”) and Chief Financial Officer of Cyngn Inc. (the “Company”).
Departed
Alain Treuer
Director
GPRE ·
Green Plains Inc.
On June 6, 2025, Alain Treuer and Ejnar Knudsen III did not stand for re-election at the 2025 annual meeting of shareholders, which effectively ended their terms as directors on our Board.
Departed
Ejnar Knudsen III
Director
GPRE ·
Green Plains Inc.
On June 6, 2025, Alain Treuer and Ejnar Knudsen III did not stand for re-election at the 2025 annual meeting of shareholders, which effectively ended their terms as directors on our Board.
Departed
Susan S. Lanigan
director
BRAND HOUSE COLLECTIVE, INC.
On June 2, 2025, Susan S. Lanigan informed the Company that she does not intend to stand for reelection at the 2025 Annual Meeting of Shareholders to be held on July 24, 2025.
Departed
Charlie Pleas, III
director
BRAND HOUSE COLLECTIVE, INC.
On June 4, 2025, Charlie Pleas, III informed the Company that he does not intend to stand for reelection at the 2025 Annual Meeting of Shareholders to be held on July 24, 2025.
Appointed
James E. Schisler
Chief Operating Officer
BRAND HOUSE COLLECTIVE, INC.
On June 2, 2025, Kirkland’s, Inc. (the “Company”) appointed James E. Schisler, age 50, as the Chief Operating Officer of the Company, effective immediately.
Departed
Marcos Galperin
Director
SATL ·
Satellogic Inc.
On June 4, 2025, Marcos Galperin notified Satellogic Inc. (the “Company”) of his decision to resign from the board of directors (the “Board”) of the Company, effective as of June 6, 2025 (the “Effective Date”).
Appointed
(interim)
David Jenkins
Chief Commercial Officer
VTAK ·
Catheter Precision, Inc.
Mr. David Jenkins, the Company’s Executive Chairman of the Board and Chief Executive Officer, will fill the role of Chief Commercial Officer until a replacement is engaged.
Departed
Marie-Claude Jacques
Chief Commercial Officer
VTAK ·
Catheter Precision, Inc.
On June 2, 2025, Catheter Precision, Inc. (the “Company”) discontinued the employment of Marie-Claude Jacques, the Company’s Chief Commercial Officer.
Departed
L. Spencer Wells
Director
ARQ ·
Arq, Inc.
As a result of their not standing for reelection at the Annual Meeting, L. Spencer Wells and Gilbert Li no longer serve as members of the Company's Board of Directors (the "Board"), effective immediately following the conclusion of the Annual Meeting.
Departed
Gilbert Li
Director
ARQ ·
Arq, Inc.
As a result of their not standing for reelection at the Annual Meeting, L. Spencer Wells and Gilbert Li no longer serve as members of the Company's Board of Directors (the "Board"), effective immediately following the conclusion of the Annual Meeting.
Departed
Simone Blank
Director
EOLS ·
Evolus, Inc.
Simone Blank voluntarily stepped down from the board of directors of the Company (the “Board”) effective on June 5, 2025, as part of a planned board refreshment and transition.
Departed
Jay H. Shah
Director
BHR ·
Braemar Hotels & Resorts Inc.
On June 2, 2025, Mr. Jay H. Shah tendered his resignation from the Board of Directors of Braemar Hotels & Resorts Inc. (the “ Company ”) to be effective as of that date.
Role change
Sushmita Koyanagi
Chief Financial Officer
LNZA ·
LanzaTech Global, Inc.
on June 2, 2025, the Board of Directors of the Company appointed Michael Heraty, Vice President – Internal Audit & SOX Compliance to serve as Chief Accounting Officer of the Company following Sushmita Koyanagi’s promotion to Chief Financial Officer.
Appointed
Michael Heraty
Chief Accounting Officer
LNZA ·
LanzaTech Global, Inc.
on June 2, 2025, the Board of Directors of the Company appointed Michael Heraty, Vice President – Internal Audit & SOX Compliance to serve as Chief Accounting Officer of the Company following Sushmita Koyanagi’s promotion to Chief Financial Officer.
Appointed
Sushmita Koyanagi
Chief Financial Officer
LNZA ·
LanzaTech Global, Inc.
Sushmita Koyanagi, the Company's then-current Chief Accounting Officer, would take on the position of Chief Financial Officer.
Departed
(interim)
Justin Pugh
Interim Chief Financial Officer
LNZA ·
LanzaTech Global, Inc.
Justin Pugh would step down from his role as the Company's interim Chief Financial Officer
Departed
Julie Peffer
Chief Financial Officer
BBAI ·
BigBear.ai Holdings, Inc.
On June 6, 2025, Julie Peffer, Chief Financial Officer, notified BigBear.ai Holdings, Inc. (“BigBear” or the “Company”) of her intention to pursue other opportunities outside of the Company.
Appointed
(interim)
Sean R. Ricker
acting Chief Financial Officer
BBAI ·
BigBear.ai Holdings, Inc.
On June 6, 2025, Sean R. Ricker was appointed acting Chief Financial Officer on an interim basis until the Company appoints a permanent replacement.
Appointed
Eric Chin
Director and Audit Committee Chair
BMRA ·
BIOMERICA INC
On the same date, the Board appointed Mr. Eric Chin to serve as an independent member of the Board, effective immediately
Departed
Cathy Coste
Director
BMRA ·
BIOMERICA INC
Effective June 4, 2025, Ms. Cathy Coste stepped down as a member of the Board of Directors
Appointed
Vincent LeVien
Class II director
CELU ·
Celularity Inc
On June 5, 2025, the Board of Directors of Celularity Inc. (the “Company”) appointed Vincent LeVien as a Class II director of the Company to serve until the Annual Meeting of Stockholders to be held in 2026.
Appointed
Jason Lobel
Director
BACK ·
IMAC Holdings, Inc.
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
Appointed
Saundra Pelletier
Director
BACK ·
IMAC Holdings, Inc.
On June 2, 2025, IMAC Holdings, Inc. (the “Company”) appointed Jason Lobel and Saundra Pelletier as a member of the Board of Directors of the Company.
Role change
Francis Leonard
President, Novocure
NVCR ·
NovoCure Ltd
In connection with his appointment of the title "President, Novocure" on June 4, 2025 (the "Award Date"), Francis Leonard, formerly the Company's Executive Vice President, President Novocure Oncology, was awarded 179,426 Restricted Share Units
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.